Veritas Pharma Inc. Reports Earnings Results for the Third Quarter Ended January 31, 2021
April 01, 2021 at 08:42 am EDT
Veritas Pharma Inc. announced earnings results for the third quarter ended January 31, 2021. For the third quarter, the company announced net loss was CAD 98,154 compared to CAD 256,074 a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.02 a year ago. For the nine months, net loss was CAD 507,130 compared to CAD 1.409 million a year ago. Basic loss per share from continuing operations was CAD 0.03 compared to CAD 0.12 a year ago.